Nemgenix Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Nemgenix General Information

Description

Provider of agricultural biotechnology services intended to control plant-parasitic nematodes and aphids. The company's services focus on the development of novel RNAi-based crop traits using bio/chemo-informatics, enabling farmers to witness improved field conditions.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Agricultural Chemicals
Other Industries
Other Agriculture
Parent Company
Green Blueprint
Primary Office
  • 32 Mumford Place
  • Unit 2
  • Balcatta, Western Australia 6021
  • Australia
+61 (08) 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nemgenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 00000 Completed Generating Revenue
5. Grant 20-Dec-2012 00000 00000 Completed Generating Revenue
4. Grant 13-Jan-2010 00000 00000 Completed Startup
3. Seed Round 31-Jan-2008 00000 00000 Completed Startup
2. Grant 21-Dec-2007 $280K Completed Startup
1. Grant 01-Jan-2007 $231K Completed Startup
To view Nemgenix’s complete valuation and funding history, request access »

Nemgenix Board Members (3)

Name Representing Role Since
Matthew Callahan Stone Ridge Ventures Board Member 000 0000
To view Nemgenix’s complete board members history, request access »

Nemgenix Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Australian Government Government 000 0000 000000 0
Department of Education and Training Government 000 0000 000000 0
Department of Industry, Innovation and Science Government 000 0000 000000 0
Stone Ridge Ventures Venture Capital Minority 000 0000 000000 0
Syngenta Ventures Corporate Venture Capital Minority 000 0000 000000 0
To view Nemgenix’s complete investors history, request access »